Larimar Therapeutics, Inc. ($LRMR)
Filing Information
| Accession Number | 0001193805-26-000205 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
5,000,000
Total Value
$25,000,000.00
P&L
-12.4% ($3,100,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 27, 2026 | Purchase | 1,084,010 | $5.00 | $5,420,050.00 | 10,622,928 | Indirect | Through Deerfield Private Design Fund III, L.P. | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Purchase | 1,084,012 | $5.00 | $5,420,060.00 | 10,622,957 | Indirect | Through Deerfield Private Design Fund IV, L.P. | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Purchase | 831,978 | $5.00 | $4,159,890.00 | 8,153,107 | Indirect | Through Deerfield Healthcare Innovations Fund, L.P. | View Details | |
Director | Common Stock | โ | Feb 27, 2026 | Purchase | 2,000,000 | $5.00 | $10,000,000.00 | 6,207,982 | Indirect | Through Deerfield Partners, L.P. | View Details |